Therapy News and Research

RSS

Blood test shows promise for predicting treatment response in patients with advanced HPV-positive throat cancer

A sensitive blood test being developed by a team of researchers at the University of Michigan Rogel Cancer Center shows promise for predicting whether patients with metastatic HPV-positive throat cancer will respond to treatment months earlier than standard imaging scans.

23 Jun 2021

AI system can rapidly identify healthy, productive skin stem cells

Stem cell therapy is at the cutting edge of regenerative medicine, but until now researchers and clinicians have had to painstakingly evaluate stem cell quality by looking at each cell individually under a microscope.

23 Jun 2021

Repurposing immunomodulatory drugs to treat COVID-19

EULAR has released new points to consider on the use of immunomodulatory drugs in the fight against severe COVID-19.

23 Jun 2021

A study on hospitalized COVID-19 patients who received plasma therapy

A new study has been published which focuses on the evaluation of the outcomes of infected COVID-19 patients who were treated with CCP therapy.

23 Jun 2021

Longitudinal study finds SARS-CoV-2 neutralizing antibodies decline a year after infection

Research led by Xin Zheng of Huazhong University of Science and Technology in Wuhan, China, found that about 90% of patients who recovered from COVID-19 continued to have IgG antibodies targeting the N-domain and receptor-binding domain of the spike protein. However, approximately 43% of patients showed signs of neutralizing antibody activity.

23 Jun 2021

GenScript and Duke-NUS announce notice of allowance for “Surrogate Virus Neutralization Technology”

GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading life sciences research and application service and product provider, and Duke-NUS Medical School, a premier, research intensive medical school, announced today that the U.S. Patent and Trade Office has issued a notice of allowance for the patent application for a novel Surrogate Virus Neutralization Technology (sVNT).

23 Jun 2021

University Hospitals in Northeast Ohio performs first innovative heart procedure

A University Hospitals (UH) patient is the first in Northeast Ohio to undergo a new, innovative procedure called CCM® therapy. UH is among the first hospitals in the United States and the only hospital in Northeast Ohio to use CCM therapy, delivered by the Optimizer® system, to treat patients suffering from heart failure.

23 Jun 2021

Study provides treatment guidance for children and adolescents with multisystem inflammatory syndrome

An analysis conducted by a group of investigators including Tamara Bradford, MD, Associate Professor of Pediatrics at LSU Health New Orleans School of Medicine, found that children and adolescents with Multisystem inflammatory syndrome in children (MIS-C) initially treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone.

22 Jun 2021

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

A new class of drugs that inhibits a "master switch" involved in the vast majority of cases of mantle cell lymphoma (MCL), a fatal subtype of non-Hodgkin's lymphoma, has been discovered by researchers at Mount Sinai.

22 Jun 2021

Protein blueprint may aid in treatments for infertility and help protect future fertility

Researchers at the University of Cincinnati College of Medicine have developed a blueprint for a protein that plays an important role in the development and regulation of reproductive organs.

22 Jun 2021

CU Cancer Center researcher investigates new treatment sequence for esophageal cancer

Looking for better ways to treat patients with esophageal cancer, University of Colorado Cancer Center member Martin McCarter, MD, is investigating whether a new treatment sequence will result in better outcomes.

22 Jun 2021

RDM Positive Impact Foundation funds $1.25 million research project to study SYNGAP1

The RDM Positive Impact Foundation is funding an ambitious $1.25 million research project at the UC Davis MIND Institute to study SYNGAP1.

22 Jun 2021

Older adult’s perceived cognitive decline may be related to changes in brain functional connectivity

Jessica Damoiseaux, Ph.D., an associate professor with the Institute of Gerontology at Wayne State University, recently published the results of a three-year study of cognitive changes in older adults.

22 Jun 2021

Transgender and gender diverse youth need high-quality medical care just as other teenagers

The Endocrine Society and a coalition of LGBTQ+ youth and reproductive health organizations argued in a joint submission to the High Court of England and Wales that transgender teenagers should be able to give informed consent to treatment the same way teenagers with other medical conditions can.

22 Jun 2021

What is the optimal dosing regimen for remdesivir in COVID-19 patients? A computational model

A team of scientists from the Pennsylvania State University, USA, recently analyzed the pharmacodynamics and pharmacokinetics of antiviral drug remdesivir using computational models. Based on the study findings, which are yet to be peer-reviewed, the scientists recommend that for effective inhibition of SARS-CoV-2 infection, remdesivir should be used with other antiviral medicines, or its dosing regimen should be optimized to improve bioavailability.

22 Jun 2021

In a murky sea of mental health apps, consumers left adrift

In the eyes of the tech industry, mental health treatment is an area ripe for disruption.

22 Jun 2021

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574).

21 Jun 2021

FLASH radiotherapy could revolutionize future tumor treatments

It could become a breakthrough for future tumor treatments with heavy ions and pave new ways: In the current experiment period FAIR-Phase 0, the GSI Helmholtzzentrum für Schwerionenforschung and the future accelerator center FAIR succeeded in performing a carbon ion FLASH experiment for the first time.

21 Jun 2021

Dual-antibody combination therapies effective against SARS-CoV-2 variants in animal study

COVID-19 therapies made from antibodies often are given to patients who are at high risk of severe illness and hospitalization. However, there have been nagging questions about whether such antibody therapies retain their effectiveness as worrisome new virus variants arise.

21 Jun 2021

Updated ACR position statement on patient safety and site of service for biologics released

The American College of Rheumatology has released an updated position statement on patient safety and site of service for biologics outlining several reasons why the ACR strongly believes infusions should be administered in a monitored health care setting with onsite supervision by a provider with appropriate training in biologic infusions.

21 Jun 2021

Therapy News and Research

Blood test shows promise for predicting treatment response in patients with advanced HPV-positive throat cancer

AI system can rapidly identify healthy, productive skin stem cells

Repurposing immunomodulatory drugs to treat COVID-19

A study on hospitalized COVID-19 patients who received plasma therapy

Longitudinal study finds SARS-CoV-2 neutralizing antibodies decline a year after infection

GenScript and Duke-NUS announce notice of allowance for “Surrogate Virus Neutralization Technology”

University Hospitals in Northeast Ohio performs first innovative heart procedure

Study provides treatment guidance for children and adolescents with multisystem inflammatory syndrome

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

Protein blueprint may aid in treatments for infertility and help protect future fertility

CU Cancer Center researcher investigates new treatment sequence for esophageal cancer

RDM Positive Impact Foundation funds $1.25 million research project to study SYNGAP1

Older adult’s perceived cognitive decline may be related to changes in brain functional connectivity

Transgender and gender diverse youth need high-quality medical care just as other teenagers

What is the optimal dosing regimen for remdesivir in COVID-19 patients? A computational model

In a murky sea of mental health apps, consumers left adrift

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

FLASH radiotherapy could revolutionize future tumor treatments

Dual-antibody combination therapies effective against SARS-CoV-2 variants in animal study

Updated ACR position statement on patient safety and site of service for biologics released

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News